xCures Inc Press Releases

• Published on March 7, 2024 - 14:00 GMT

  

  xCures Announces Issuance of Groundbreaking Patent

  USPTO awards patent for AI tech enabling virtual trials, enhancing clinical decisions through continuous learning from patient experiences. OAKLAND, CALIFORNIA, UNITED STATES, March 7, 2024 /⁨EINPresswire.com⁩/ -- xCures, Inc., a leader in health …

  Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
• Published on December 13, 2023 - 15:15 GMT

  

  xCures and Aetion® Further Enhance Partnership with Rich Real-World Datasets

  Partnership now includes access to five comprehensive oncology datasets, enhancing real-world evidence in cancer research. OAKLAND, CALIFORNIA, UNITED STATES, December 13, 2023 /⁨EINPresswire.com⁩/ -- In the realm of oncology research, diverse, …

  Distribution channels: Business & Economy, Companies ...
• Published on December 6, 2023 - 15:15 GMT

  

  xCures to offer clinical data extraction as a service in AWS Marketplace

  AWS cloud configurations help xCures customers leverage the company’s data gathering and structuring services while maintaining secure private ownership of data OAKLAND, CALIFORNIA, UNITED STATES, December 6, 2023 /⁨EINPresswire.com⁩/ -- xCures, a …

  Distribution channels: Business & Economy, Companies ...
• Published on June 20, 2023 - 17:15 GMT

  

  xCures and DDRFA partner to make an impact on patient-driven DIPG & DMG research

  xCures’ technology harnesses real-time patient data and makes it accessible for scientific exploration and to improve patient options. OAKLAND, CALIFORNIA, UNITED STATES, June 20, 2023 /⁨EINPresswire.com⁩/ -- Today, xCures and the Diffuse Intrinsic …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
• Published on June 6, 2023 - 14:15 GMT

  

  CureMatch and xCures Partner to Revolutionize the Standard for Precision Cancer Treatment Processes

  CureMatch will leverage xCures technology that automatically creates a comprehensive outline of a patient’s medical history to improve treatment recommendations OAKLAND, CALIFORNIA, UNITED STATES, June 6, 2023 /⁨EINPresswire.com⁩/ -- CureMatch, Inc., a …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
• Published on May 26, 2023 - 14:15 GMT

  

  xCures showcases the Power of its Real-time Clinical data platform at ASCO Annual Meeting 2023

  Real-world patient data gives valuable insights, such as collecting data on rare cancers and showing real-world side effects of treatment combinations. OAKLAND, CALIFORNIA, UNITED STATES, May 26, 2023 /⁨EINPresswire.com⁩/ -- xCures, a healthcare …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
• Published on February 15, 2023 - 15:15 GMT

  

  Genome Medical and xCures Partner to Enhance Genetic Services with Personalized Clinical Data

  OAKLAND, CALIFORNIA, UNITED STATES, February 15, 2023 /⁨EINPresswire.com⁩/ -- Genome Medical and xCures have joined forces to provide patients with a new level of personalized care. Through this collaboration, Genome Medical's genetic counselors will …

  Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
• Published on December 20, 2022 - 15:15 GMT

  

  xCures partners with RenovoRx to assist patients in accessing RenovoRx’s TIGeR-PaC study

  RenovoRx's Phase III clinical study is open to pancreatic adenocarcinoma patients and focuses on extending overall survival and improving quality of life. OAKLAND, CALIFORNIA, UNITED STATES, December 20, 2022 /⁨EINPresswire.com⁩/ -- xCures, Inc. is …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
• Published on November 15, 2022 - 11:49 GMT

  

  xCures presents clinical and translational research with two posters at the 2022 SNO Annual Meeting

  XCELSIOR registry showcases its power in using real-world datasets and clinical outcomes to aid decision-making and treatment options for CNS cancer patients. OAKLAND, CALIFORNIA, UNITED STATES, November 15, 2022 /⁨EINPresswire.com⁩/ -- Today, xCures …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...
• Published on November 8, 2022 - 14:45 GMT

  

  Finally, cancer patients have real-time access to their medical records

  Recent changes to patients’ data rights enable xCures’ platform to automatically retrieve patient records from institutions and generate powerful care summaries OAKLAND, CALIFORNIA, UNITED STATES, November 8, 2022 /⁨EINPresswire.com⁩/ -- Last month, the …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Law ...
• Published on October 24, 2022 - 17:39 GMT

  

  xCures and mProbe partner to help cancer patients determine optimal treatments

  xCures partners with mProbe, to leverage their targeted proteomics platform for profiling individual patients' cancer tissues for actionable drug targets OAKLAND, CALIFORNIA, UNITED STATES, October 24, 2022 /⁨EINPresswire.com⁩/ -- xCures, Inc. is …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
• Published on August 25, 2022 - 14:05 GMT

  

  xCures and Oblato announce the launch of a Compassionate Use program for OKN-007

  Oblato’s first-in-class small molecular OKN-007 will be available through a newly opened compassionate use protocol. OAKLAND, CALIFORNIA, UNITED STATES, August 25, 2022 /⁨EINPresswire.com⁩/ -- xCures, Inc., a clinical study platform provider, and Oblato, …

  Distribution channels: Business & Economy, Companies ...
• Published on August 24, 2022 - 14:05 GMT

  

  Pancreatic Cancer Patients Will Now Have Remote Access to Precision Nutrition Trial Through New Partnership

  xCures and Vault Health integration creates a decentralized platform to benefit pancreatic cancer research and facilitate enrollment in Faeth’s NEAAR-001 study OAKLAND, CALIFORNIA, UNITED STATES, August 24, 2022 /⁨EINPresswire.com⁩/ -- xCures, Inc. is …

  Distribution channels: Business & Economy, Companies ...
• Published on July 19, 2022 - 14:15 GMT

  

  xCures partners with Travera to support advanced carcinoma patients and their physicians

  Decentralized clinical trial for patients with advanced carcinomas helps determine their cancer’s response to specific drugs OAKLAND, CALIFORNIA, UNITED STATES, July 19, 2022 /⁨EINPresswire.com⁩/ -- xCures, Inc. is proud to announce their partnership with …

  Distribution channels: Business & Economy, Companies ...
• Published on June 21, 2022 - 14:15 GMT

  

  xCures and Novocure® partner to better understand quality of life in glioblastoma

  Innovative collaboration focused on developing the first comprehensive Quality of Life dataset for glioblastoma patients OAKLAND, CALIFORNIA, UNITED STATES, June 21, 2022 /⁨EINPresswire.com⁩/ -- ] xCures, Inc., is proud to announce their partnership with …

  Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
• Published on June 3, 2022 - 16:45 GMT

  

  Prognos Health and xCures Partner to enable Access to Real World Oncology Datasets

  The new collaboration focuses on improving outcomes by continuous learning from every patient’s journey across diverse datasets CHICAGO, IL, UNITED STATES, June 3, 2022 /⁨EINPresswire.com⁩/ -- Today, at the annual meeting of the American Society of …

  Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
• Published on June 2, 2022 - 18:00 GMT

  

  xCures joins C-Path's Cure Drug Repurposing Collaboratory to Deliver AI-enabled Data Abstraction of Health Records

  Members of CDRC will be able to utilize xCures’ technology to quickly abstract and structure clinical data to support drug repurposing studies in rare cancer. OAKLAND, CALIFORNIA, UNITED STATES, June 2, 2022 /⁨EINPresswire.com⁩/ -- xCures today announced …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
• Published on March 10, 2022 - 21:00 GMT

  

  xCures announces real world biomarker study for patients with FGFR-mutant bladder cancer receiving Balversa®

  Tyra Biosciences supported study investigates if non-invasive blood and urine samples provide biomarkers to assess clinical response to erdafitinib treatment OAKLAND, CALIFORNIA, UNITED STATES, March 10, 2022 /⁨EINPresswire.com⁩/ -- Today, xCures …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...
• Published on March 3, 2022 - 14:00 GMT

  

  xCures and BioSpark partner to boost Real World Oncology Data offerings

  New partnership allows for a 40,000+ patient dataset to unlock new insights into cancer treatments and outcomes. OAKLAND, CA, UNITED STATES, March 3, 2022 /⁨EINPresswire.com⁩/ -- xCures, Inc. and BioSpark, Inc. are proud to announce their strategic …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
• Published on February 17, 2022 - 14:00 GMT

  

  TARGET: Cancer podcast to be hosted by media personality Dr. Sanjay Juneja - TheOncDoc

  Oncologist and cancer educator Dr. Sanjay Juneja will host xCures’ informative podcast on cancer and technology OAKLAND, CA, UNITED STATES, February 17, 2022 /⁨EINPresswire.com⁩/ -- xCures, a direct-to-patient, and direct-to-physician oncology platform, …

  Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...